Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Dissecting the role of CD36 on Tbet+ B cells during obesity and autoimmunity

Award Number: R21AI196999
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/05/2026
PERIOD OF PERFORMANCE END DATE: 01/31/2028

Group Awards By:

View Award Description

Dissecting the role of CD36 on Tbet+ B cells during obesity and autoimmunity - CD21-CD23- CD11c+ Tbet+ Age Associated B Cells or ABCs, expand in primary immune and peripheral tissues during chronic conditions such as aging, autoimmune diseases, atherosclerosis, and obesity. These ABCs largely produce IgG2a/c autoantibodies which exacerbate autoimmunity and metabolic dysfunction, positioning them as a promising therapeutic target for a broad array of inflammatory and infectious diseases. Furthermore, ABCs have recently been found to inhibit germinal center responses to conventional antigens such as those in most effective vaccines, which could explain the poor vaccine outcomes in elderly, autoimmune, and obese patients. As such, this suggests that blocking ABCs may improve vaccine responses across a broad array of platforms. ABCs expand in vitro and in vivo in response to a combination of TLR agonists, cytokines like IFNg and IL-21 as well as CD4+ T cell help, but the nature and coordination of signals which mediate ABC expansion and effector function remain inadequately understood. We recently discovered that ABC cells express unexpectedly high levels of class B scavenger receptor and fatty acid translocase CD36. Even more interesting, expansion of ABCs during obesity or in response to TLR7 inflammatory stimulation requires CD36, suggesting a role for CD36 in stimulation or maintenance of this unique B cell subset during chronic inflammation of obesity and autoimmunity. CD36 is capable of a myriad of different roles, including innate signaling, efficient uptake of antigen and metabolic reprograming, any one of which could be contributing to ABC activity. For example, CD36 mediated fatty acid uptake and subsequent PPAR-beta signaling support mitochondrial oxidative phosphorylation over glycolysis. In addition to mediating lipid uptake for metabolic regulation, CD36 also binds long chain fatty acids including oxidized phospholipids and pattern associated molecular patterns (DAMPS/PAMPS) such as apoptotic cells and amyloid proteins which could be presented by MHC II to engage helper T cells. CD36 engagement also triggers intracellular signaling cascades leading to innate activation and secretion of inflammatory cytokines. This project aims to combine unique mouse strains engineered to lack CD36 selectively in B cells with inflammatory in vivo mouse models to determine the relative contribution of CD36 to mediating antigen uptake and presentation, innate immune activation, and metabolic engagement by ABC cells during obesity or autoimmune disease. Elaborating a better understanding of signals employed by CD36 during activation of ABCs will allow targeted clinical interventions to slow their inflammatory contribution to disease and also improve immune responses to vaccination or infection for patients with obesity, autoimmune disease, or related chronic inflammatory conditions.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $421,223 )
2026	2026	THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO	7703 FLOYD CURL DR	SAN ANTONIO	TX	78229	BEXAR	USA	Allergy and Infectious Diseases Research	000	1	2/5/2026	NEW	$421,223
														Subtotal = $421,223

Grand Total All Awards = $421,223

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Dissecting the role of CD36 on Tbet+ B cells during obesity and autoimmunity

Award Number: R21AI196999

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/05/2026

PERIOD OF PERFORMANCE END DATE: 01/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer